High clusterin expression correlates with a poor outcome in stage II colorectal cancers.
AffiliationCentre for Colorectal Disease, St Vincent's University Hospital, Elm Park, Dublin, 4, Ireland.
Aged, 80 and over
In Situ Nick-End Labeling
Reproducibility of Results
Tumor Markers, Biological/*metabolism
MetadataShow full item record
CitationCancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):393-9. Epub 2009 Jan 20.
JournalCancer epidemiology, biomarkers & prevention : a publication of the American, Association for Cancer Research, cosponsored by the American Society of, Preventive Oncology
AbstractThe role of clusterin in tumor growth and progression remains unclear. Overexpression of cytoplasmic clusterin has been studied in aggressive colon tumors; however, no correlation between clusterin expression and survival in colorectal cancer has been identified to date. We assessed levels of clusterin expression in a group of stage II colorectal cancer patients to assess its utility as a prognostic marker. The study included 251 patients with stage II colorectal cancer. Tissue microarrays were constructed and immunohistochemistry done and correlated with clinical features and long term outcome. Dual immunofluorescence and confocal microscopy were used with terminal deoxynucleotidyl-transferase-mediated dUTP nick-end labeling probes and clusterin antibody to assess the degree of co localization. Percentage epithelial cytoplasmic staining was higher in tumor compared with nonadjacent normal mucosa (P < 0.001). Within the stromal compartment, percentage cytoplamic staining and intensity was lower in tumor tissue compared with normal nonadjacent mucosa (P < or = 0.001). Survival was significantly associated with percentage epithelial cytoplasmic staining (P < 0.001), epithelial cytoplasmic staining intensity (P < 0.001), percentage stromal cytoplasmic staining (P = 0.002), and stromal cytoplasmic staining intensity (P < 0.001). Clusterin levels are associated with poor survival in stage II colorectal cancer.
- Overexpression of clusterin in human hepatocellular carcinoma.
- Authors: Kang YK, Hong SW, Lee H, Kim WH
- Issue date: 2004 Nov
- Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.
- Authors: Xie D, Lau SH, Sham JS, Wu QL, Fang Y, Liang LZ, Che LH, Zeng YX, Guan XY
- Issue date: 2005 Jan 15
- [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
- Authors: Chen W, Xie D, Luo JH, Wang CX, Tao Y, Zheng KL, Mei H
- Issue date: 2006 Jan 15
- Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
- Authors: Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ
- Issue date: 2009 Feb
- Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
- Authors: Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S
- Issue date: 2009